EGLN1 and paraganglioma: Furthermore, PHD2 germline mutations can have oncogenic potential in vitro [13] and analysis of paraganglioma cells suggests PHD2 may have tumor suppressor activity since the tumor cells showed loss of heterozygosity of wild-type PHD2 allele [6].